Wei Xu

7.6k total citations
367 papers, 4.5k citations indexed

About

Wei Xu is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology. According to data from OpenAlex, Wei Xu has authored 367 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 189 papers in Pathology and Forensic Medicine, 157 papers in Genetics and 110 papers in Oncology. Recurrent topics in Wei Xu's work include Lymphoma Diagnosis and Treatment (181 papers), Chronic Lymphocytic Leukemia Research (145 papers) and Viral-associated cancers and disorders (48 papers). Wei Xu is often cited by papers focused on Lymphoma Diagnosis and Treatment (181 papers), Chronic Lymphocytic Leukemia Research (145 papers) and Viral-associated cancers and disorders (48 papers). Wei Xu collaborates with scholars based in China, Netherlands and United States. Wei Xu's co-authors include Jianyong Li, Lei Fan, Huayuan Zhu, Jin‐Hua Liang, Kourong Miao, Yi Xia, Li Wang, Jia‐Zhu Wu, Danxia Zhu and Jianyong Li and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Wei Xu

326 papers receiving 4.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wei Xu China 34 1.8k 1.6k 1.4k 1.4k 979 367 4.5k
Alexander Egle Austria 35 2.0k 1.1× 903 0.6× 1.2k 0.9× 1.5k 1.1× 1.2k 1.2× 153 4.2k
Thierry Fest France 41 1.4k 0.8× 1.6k 1.0× 862 0.6× 1.8k 1.3× 2.1k 2.2× 145 5.0k
Steven H. Bernstein United States 34 1.4k 0.8× 1.9k 1.2× 1.1k 0.8× 1.9k 1.4× 1.7k 1.7× 109 5.1k
David Spaner Canada 35 1.4k 0.8× 954 0.6× 1.4k 1.0× 1.9k 1.4× 1.8k 1.9× 123 4.7k
Penelope Korkolopoulou Greece 40 1.9k 1.1× 925 0.6× 679 0.5× 1.2k 0.8× 502 0.5× 208 4.6k
Fortunato Morabito Italy 39 2.0k 1.1× 1.3k 0.8× 1.7k 1.2× 1.5k 1.1× 1.1k 1.1× 294 5.0k
Luca Laurenti Italy 37 1.3k 0.8× 1.4k 0.9× 2.5k 1.8× 840 0.6× 1.7k 1.7× 220 4.8k
Junya Kuroda Japan 34 2.0k 1.1× 676 0.4× 707 0.5× 1.5k 1.1× 950 1.0× 217 4.7k
Mingzhi Zhang China 28 1.6k 0.9× 832 0.5× 398 0.3× 1.2k 0.8× 722 0.7× 207 3.4k
Didier Bouscary France 40 3.5k 2.0× 821 0.5× 1.1k 0.8× 1.4k 1.0× 993 1.0× 163 6.3k

Countries citing papers authored by Wei Xu

Since Specialization
Citations

This map shows the geographic impact of Wei Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Xu more than expected).

Fields of papers citing papers by Wei Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Xu. The network helps show where Wei Xu may publish in the future.

Co-authorship network of co-authors of Wei Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Wei Xu. A scholar is included among the top collaborators of Wei Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei Xu. Wei Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wei, Haijun, Longwu Geng, Xinchi Shang, et al.. (2025). Metabolomics analysis reveals the mechanism for improving the growth performance and flesh quality of Aral barbel Luciobarbus brachycephalus by environmental alkalinity. SHILAP Revista de lepidopterología. 19. 101670–101670.
3.
Wang, Xiaping, Tongshan Wang, Wei Xu, et al.. (2024). Construction of a TAN-associated risk score model with integrated multi-omics data analysis and clinical validation in gastric cancer. Life Sciences. 349. 122731–122731. 1 indexed citations
4.
Wu, Jia‐Zhu, Jin‐Hua Liang, Li Wang, et al.. (2024). Cause-specific mortality in a population-level cohort of diffuse large B-cell lymphoma following chemotherapy in the early 21st century. Annals of Hematology. 103(5). 1675–1685. 1 indexed citations
5.
Hua, Wei, Yue Li, Jia‐Zhu Wu, et al.. (2024). Analysis of CCND3 mutations in diffuse large B-cell lymphoma. Annals of Hematology. 103(12). 5729–5739. 3 indexed citations
6.
Wu, Yifan, Qunhui Yuan, Hao Shen, et al.. (2024). The prognostic significance of MYC/BCL2 double expression in DLBCL in the genetic classification era. Cancer Science. 116(1). 257–270. 1 indexed citations
7.
8.
Du, Jingcheng, Linghao Liu, Qian Sun, et al.. (2024). Heterocycles for direct air capture and MOFs prepared from CO2 utilization. Journal of Materials Chemistry A. 12(13). 7711–7723. 11 indexed citations
9.
Liu, Lin, Wei Xu, Kaiwen Li, et al.. (2023). Kv1.3 mediates ox-LDL-induced vascular smooth muscle cell proliferation through JAK2/STAT3 signaling pathway. Archives of Biochemistry and Biophysics. 746. 109719–109719.
10.
Zhang, Jing, Qingqing Chen, Yi Xia, et al.. (2023). The Clinical Significance and Prognostic Role of Whole-Blood Epstein-Barr Virus DNA in Lymphoma-Associated Hemophagocytic Lymphohistiocytosis. Journal of Clinical Immunology. 43(6). 1302–1310. 9 indexed citations
11.
Dû, Katell Le, et al.. (2023). CTPS1 acts as a prognostic biomarker and therapeutic target in mantle cell lymphoma. Hematological Oncology. 41(S2). 253–254.
12.
Liang, Jin‐Hua, Yimin Ren, Rui Gao, et al.. (2023). MYC‐induced cytidine metabolism regulates survival and drug resistance via cGas‐STING pathway in mantle cell lymphoma. British Journal of Haematology. 202(3). 550–565. 9 indexed citations
13.
Hua, Wei, Hua Shen, Hang Yin, et al.. (2023). Molecular features possessed in the ctDNA reveal heterogeneity and predict outcome in newly diagnosed peripheral T‐cell lymphoma. Hematological Oncology. 41(S2). 336–338. 1 indexed citations
14.
15.
Cao, Xin, Yilin Kong, Li Wang, et al.. (2021). Circulating low CD4+/CD8+ ratio is associated with poor prognosis in Waldenstrom macroglobulinemia patients. Annals of Hematology. 100(4). 995–1002. 7 indexed citations
16.
Xu, Wei, Mingjiong Zhang, Yue Li, et al.. (2021). YAP manipulates proliferation via PTEN/AKT/mTOR-mediated autophagy in lung adenocarcinomas. Cancer Cell International. 21(1). 30–30. 32 indexed citations
17.
Song, Yuqin, Keshu Zhou, Dehui Zou, et al.. (2020). Treatment of Patients with Relapsed or Refractory Mantle–Cell Lymphoma with Zanubrutinib, a Selective Inhibitor of Bruton's Tyrosine Kinase. Clinical Cancer Research. 26(16). 4216–4224. 111 indexed citations
18.
19.
Li, Xiaofei, et al.. (2020). [Clinicopathological study of large B-cell lymphoma with IRF4 rearrangement].. PubMed. 49(10). 1003–1008. 2 indexed citations
20.
Zhao, Xiao‐Fan, et al.. (2019). Research Progress in microRNA-Based Therapy for Gastric Cancer. SHILAP Revista de lepidopterología. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alexander Egle Breakdown of academic impact, for papers by Thierry Fest Breakdown of academic impact, for papers by Steven H. Bernstein Breakdown of academic impact, for papers by David Spaner Breakdown of academic impact, for papers by Penelope Korkolopoulou Breakdown of academic impact, for papers by Fortunato Morabito Breakdown of academic impact, for papers by Luca Laurenti Breakdown of academic impact, for papers by Junya Kuroda Breakdown of academic impact, for papers by Mingzhi Zhang Breakdown of academic impact, for papers by Didier Bouscary
Rankless by CCL
2026